| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| - |
Clinical observation and analysis of ocular complications after renal transplantation Third Xiangya Hospital of Central South University |
|
|
|
2025-04-20 | 261 | Patient list |
| ChiCTR2200059326 |
Evaluation of the efficacy of the real-world hormones for improving visual function in high myopia The Scond Xiangya Hospital of Central South University |
|
Therapy Study |
Post-market |
2023-07-21 | 797 | Patient list |
| (2021)伦审临研第156号 |
Clinical Research Ethics Committee of the Second Xiangya Hospital of Central South University |
cardiac valve disease |
Therapy Study |
Premarket |
2022-07-21 | 1142 | Patient list |
| ChiCTR2200059753 |
Xiangya Hospital of Central South University |
|
Therapy Study |
Premarket |
2022-04-22 | 1196 | Patient list |
| 无 |
Xiangya Hospital of Central South University |
acute myocardial infarction |
|
|
2022-03-24 | 891 | Patient list |
| ChiCTR2200055291 |
The third Xiangya Hospital of Central South University |
|
|
|
2021-12-18 | 1198 | Patient list |
| ChiCTR2100053126 |
The Third Xiangya Hospital of Central South University |
functional dyspepsia |
Therapy Study |
Post-market |
2021-11-11 | 1130 | Patient list |
| ChiCTR2100049930 |
TheThird Xiangya Hospital of Central South University |
Perioperative fluid treatment |
Therapy Study |
Premarket |
2021-08-12 | 1009 | Patient list |
| ChiCTR2100048125 |
Xiangya Hospital of Central South University |
Pre-frailty |
Therapy Study |
|
2021-07-02 | 1150 | Patient list |
| NA |
The Second Xiangya Hospital of Central South University |
|
Diagnostic Accuracy Test |
Post-market |
2020-10-06 | 1038 | Patient list |




